Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Effector Therapeutics
11180 Roselle Street
San Diego, CA 92121
Phone: 858-925-8215
http://effector.com/

eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of selective translation regulators as a new class of small molecule therapeutics for cancer. The company's investigational compounds are designed to restore translational control to halt underlying disease mechanisms while preserving healthy physiological processes. eFFECTOR's most advanced program focuses on the development of eFT508. The company has additional selective translation regulator programs currently in discovery and development and maintains global rights to all of its development programs.

Key Contact
Name
Steve Worland
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
07/24/17 $38,600,000 Series C AbbVie Biotech Ventures
Abingworth
Alexandria Real Estate Equities
Altitude Life Science Ventures
Astellas Venture Management
BioMed Ventures
Novartis Venture Funds
Pfizer Strategic Investments Group
Sectoral Asset Management
SR One
The Column Group
US Venture Partners
undisclosed


Featured Reading